SND1 and hepatocellular carcinoma: Overexpression and knockdown studies in human HCC cells and studies using a hepatocyte-specific SND1 transgenic mouse established SND1 as an oncogene for HCC, and a selective SND1 inhibitor, 3′,5′-deoxythymidine bisphosphate (pdTp) inhibited growth of human HCC tumors in s.c. or the orthotopic model in mice [73,106,107].